πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12286657

Methods and compositions

United Kingdom Research and Innovation Β· Granted Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12268749

Cell-penetrating peptides

United Kingdom Research and Innovation Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11980637

Compositions comprising nanosilica particles and their use in methods of activating T lymp

United Kingdom Research and Innovation Β· Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11833171

Materials and methods relating to stabilised polymeric silicate compositions

United Kingdom Research and Innovation Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11684572

Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat

United Kingdom Research and Innovation Β· Granted Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11567073

Receptor tyrosine kinase biomarkers

United Kingdom Research and Innovation Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11369697

Liposome nanoparticles for tumor magnetic resonance imaging

United Kingdom Research and Innovation Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11364211

Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

United Kingdom Research and Innovation Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11337941

Inhibitors and their uses

United Kingdom Research and Innovation Β· Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11331286

Inhibitors and their uses

United Kingdom Research and Innovation Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11154519

Inhibitors and their uses

United Kingdom Research and Innovation Β· Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11007217

Compositions comprising nanosilica particles and their use in methods of activating T lymp

United Kingdom Research and Innovation Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11000502

Antimicrobial compositions comprising copper-hydroxypyrone complexes

United Kingdom Research and Innovation Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10954198

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10898511

Materials and methods relating to stabilised polymeric silicate compositions

United Kingdom Research and Innovation Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10882895

Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

United Kingdom Research and Innovation Β· Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10722459

Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat

United Kingdom Research and Innovation Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596227

Polypeptide targeting to mitochondria

United Kingdom Research and Innovation Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10526297

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10421805

Anti-hepatitis C antibodies and antigen binding fragments thereof

United Kingdom Research and Innovation Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10208100

Angiopoietin-2 specific TIE2 receptor

United Kingdom Research and Innovation Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10201499

Nanoparticle formulation

United Kingdom Research and Innovation Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10100020

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted